Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
xCures
AddedFeb 15, 2024
UpdatedJun 26, 2026
xCures

xCures

Series B

AI-based precision oncology platform revolutionizing treatment through genomics and precision medicine.

HQ
Oakland, CA, US
Founded
2018
Overview
Compare
Fundraising
Employees
News
Website

Founded with a mission to revolutionize cancer treatment, xCures leverages an AI-based precision oncology platform to integrate genomics and precision medicine. The company aims to transform the drug-centric treatment development process and streamline the capture and delivery of treatment knowledge to healthcare providers. xCures offers advanced solutions that enable personalized treatment plans for cancer patients, focusing on improving outcomes through data-driven insights and cutting-edge technology.

Notable figures associated with xCures include experts in oncology, genomics, and artificial intelligence, who contribute to the company's innovative approach. The startup has attracted significant investment from leading venture capital firms specializing in healthcare and technology. Key achievements include successful implementation of their platform in clinical settings, resulting in improved patient outcomes and streamlined treatment processes. xCures is making a substantial impact on the oncology field by enhancing the precision and effectiveness of cancer treatments.

xCures - Similar Companies

VieCure logo

VieCure

viecure.com

GenomOncology logo

GenomOncology

genomoncology.com

Precision Health AI logo

Precision Health AI

Triomics logo

Triomics

triomics.com

D2G Oncology logo

D2G Oncology

d2g-oncology.com

Blueprint Medicines logo

Blueprint Medicines

Cure Forward logo

Cure Forward

Freenome logo

Freenome

freenome.com

Certis Oncology Solutions logo

Certis Oncology Solutions

certisoncology.com

Strata Oncology logo

Strata Oncology

strataoncology.com

ConcertAI logo

ConcertAI

concertai.com

First Ascent Biomedical logo

First Ascent Biomedical

firstascentbio.com

NextCure logo

NextCure

nextcure.com

Predictive Oncology logo

Predictive Oncology

OnCusp Therapeutics logo

OnCusp Therapeutics

oncusptx.com

xCures - Quick Facts

Who are xCures' competitors?

Companies similar to xCures include VieCure, GenomOncology, Precision Health AI and Triomics.

When was xCures founded?

xCures was founded in 2018.

Where is xCures' headquarters located?

xCures' headquarters is located in Oakland, CA, US.

When was xCures' last funding round?

xCures' most recent funding round was for $46M (USD) in June 2026.

How much has xCures raised to-date?

As of Jun 24, 2026, xCures has raised a total of $84M (USD).

How many employees does xCures have?

xCures has 45 employees as of Feb 4, 2024.

xCures - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • SaaS
Customer
  • Enterprise
Main Product
  • Oncology Software
Tags
  • AI Operations
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 9 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified